BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10874131)

  • 1. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine.
    Kamal MA; Greig NH; Alhomida AS; Al-Jafari AA
    Biochem Pharmacol; 2000 Aug; 60(4):561-70. PubMed ID: 10874131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of human erythrocyte acetylcholinesterase inhibition by a novel derivative of physostigmine: phenserine.
    al-Jafari AA; Kamal MA; Greig NH; Alhomida AS; Perry ER
    Biochem Biophys Res Commun; 1998 Jul; 248(1):180-5. PubMed ID: 9675107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the toxicological effect of tacrine (Cognex) on human retinal acetylcholinesterase activity.
    Alhomida AS; Al-Rajhi AA; Kamal MA; Al-Jafari AA
    Toxicology; 2000 May; 147(1):33-9. PubMed ID: 10837930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics for camel (Camelus dromedarius) retina acetylcholinesterase inhibition by methotrexate in vitro.
    al-Jafari A; al-Khwyter F; Kamal MA; Alhomida AS
    Jpn J Pharmacol; 1996 Sep; 72(1):49-55. PubMed ID: 8902599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the nature of camel retinal acetylcholinesterase: inhibition by hexamethonium.
    Alhomida AS; Kamal MA; al-Jafari AA
    J Enzyme Inhib; 1997 Dec; 12(4):303-11. PubMed ID: 9502051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7) in vitro.
    Kamal MA
    Biochem Mol Biol Int; 1997 Sep; 43(1):89-97. PubMed ID: 9315286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of bovine retinal acetylcholinesterase (E.C. 3.1.1.7) toward tacrine: kinetic characterization.
    al-Jafari AA; Kamal MA; Alhomida AS
    J Biochem Mol Toxicol; 1998; 12(4):245-51. PubMed ID: 9580877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of human erythrocyte membrane-bound acetylcholinesterase inhibition by cisplatin at reversible phase.
    Kamal MA
    Anticancer Res; 1996; 16(6B):3725-30. PubMed ID: 9042248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of human erythrocyte acetylcholinesterase (EC3.1.1.7) by an antineoplastic drug methotrexate.
    Kamal MA; Nasim FH; al-Jafari AA
    Mol Cell Biochem; 1996 Jun; 159(1):47-53. PubMed ID: 8813709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sevin on kinetic parameters of camel retina acetylcholinesterase.
    Kamal MA
    Biochem Mol Biol Int; 1997 Jun; 42(2):235-46. PubMed ID: 9238521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease.
    Yu Q; Holloway HW; Utsuki T; Brossi A; Greig NH
    J Med Chem; 1999 May; 42(10):1855-61. PubMed ID: 10346939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the effect of lannate on kinetic parameters of acetylcholinesterase: slightly concave mixed-type of inhibition system.
    Kamal MA
    Biochem Mol Biol Int; 1997 Dec; 43(6):1183-93. PubMed ID: 9442915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of the inhibition of acetylcholinesterase from desert cobra (Walterinnesia aegyptia) venom by local anesthetics: procaine and tetracaine.
    al-Jafari AA; Kamal MA; Duhaiman AS; Alhomida AS
    J Enzyme Inhib; 1996 Oct; 11(2):123-34. PubMed ID: 9204401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine.
    al-Jafari AA
    J Ocul Pharmacol Ther; 1996; 12(4):503-14. PubMed ID: 8951687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the inhibition of camel retina acetylcholinesterase activity by cycloheximide in vitro.
    al-Jafari AA; Kamal MA; Alhomida AS
    Cell Biol Toxicol; 1998 Jun; 14(3):167-74. PubMed ID: 9689490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic analysis of the inhibition of human butyrylcholinesterase with cymserine.
    Kamal MA; Al-Jafari AA; Yu QS; Greig NH
    Biochim Biophys Acta; 2006 Feb; 1760(2):200-6. PubMed ID: 16309845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational and Kinetic Studies of Acetylcholine Esterase Inhibition by Phenserine.
    Tabrez S; Damanhouri GA
    Curr Pharm Des; 2019; 25(18):2108-2112. PubMed ID: 31258059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.
    Perola E; Cellai L; Lamba D; Filocamo L; Brufani M
    Biochim Biophys Acta; 1997 Nov; 1343(1):41-50. PubMed ID: 9428657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of human erythrocyte acetylcholinesterase inhibition by cis-diamminediaquaplatinum (II).
    Kamal MA
    Anticancer Res; 1997; 17(6D):4487-91. PubMed ID: 9494556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of cyclophosphamide on camel retina acetylcholinesterase activity.
    al-Khwyter F; Kamal MA; al-Jafari AA
    Toxicol Lett; 1996 Oct; 87(2-3):69-76. PubMed ID: 8914613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.